vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Fortrea Holdings Inc. (FTRE). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.2B vs $660.5M, roughly 1.9× Fortrea Holdings Inc.). Alignment Healthcare, Inc. runs the higher net margin — 0.9% vs -4.9%, a 5.8% gap on every dollar of revenue. On growth, Fortrea Holdings Inc. posted the faster year-over-year revenue change (-5.2% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs -0.1%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Fortrea Holdings Inc. is an American contract research organization organized in Delaware and headquartered in Durham, North Carolina with operations in 90 countries. Its customers are primarily in the pharmaceutical, biotechnology, and medical device industries.

ALHC vs FTRE — Head-to-Head

Bigger by revenue
ALHC
ALHC
1.9× larger
ALHC
$1.2B
$660.5M
FTRE
Growing faster (revenue YoY)
FTRE
FTRE
+69.5% gap
FTRE
-5.2%
-74.7%
ALHC
Higher net margin
ALHC
ALHC
5.8% more per $
ALHC
0.9%
-4.9%
FTRE
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
34.6%
-0.1%
FTRE

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ALHC
ALHC
FTRE
FTRE
Revenue
$1.2B
$660.5M
Net Profit
$11.4M
$-32.5M
Gross Margin
Operating Margin
-2.1%
Net Margin
0.9%
-4.9%
Revenue YoY
-74.7%
-5.2%
Net Profit YoY
46.9%
EPS (diluted)
$-0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
FTRE
FTRE
Q1 26
$1.2B
Q4 25
$1.0B
$660.5M
Q3 25
$993.7M
$701.3M
Q2 25
$1.0B
$710.3M
Q1 25
$926.9M
$651.3M
Q4 24
$701.2M
$697.0M
Q3 24
$692.4M
$674.9M
Q2 24
$681.3M
$662.4M
Net Profit
ALHC
ALHC
FTRE
FTRE
Q1 26
$11.4M
Q4 25
$-11.0M
$-32.5M
Q3 25
$3.7M
$-15.9M
Q2 25
$15.7M
$-374.9M
Q1 25
$-9.1M
$-562.9M
Q4 24
$-31.1M
$-61.2M
Q3 24
$-26.4M
$-27.9M
Q2 24
$-24.0M
$-138.4M
Operating Margin
ALHC
ALHC
FTRE
FTRE
Q1 26
Q4 25
-1.0%
-2.1%
Q3 25
0.8%
-1.2%
Q2 25
2.2%
-46.5%
Q1 25
-0.6%
-79.9%
Q4 24
-3.2%
-8.0%
Q3 24
-2.8%
-2.7%
Q2 24
-2.7%
-7.7%
Net Margin
ALHC
ALHC
FTRE
FTRE
Q1 26
0.9%
Q4 25
-1.1%
-4.9%
Q3 25
0.4%
-2.3%
Q2 25
1.5%
-52.8%
Q1 25
-1.0%
-86.4%
Q4 24
-4.4%
-8.8%
Q3 24
-3.8%
-4.1%
Q2 24
-3.5%
-20.9%
EPS (diluted)
ALHC
ALHC
FTRE
FTRE
Q1 26
Q4 25
$-0.04
$-0.25
Q3 25
$0.02
$-0.17
Q2 25
$0.07
$-4.14
Q1 25
$-0.05
$-6.25
Q4 24
$-0.15
$-0.68
Q3 24
$-0.14
$-0.31
Q2 24
$-0.13
$-1.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
FTRE
FTRE
Cash + ST InvestmentsLiquidity on hand
$705.6M
$174.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$206.9M
$563.5M
Total Assets
$1.3B
$2.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
FTRE
FTRE
Q1 26
$705.6M
Q4 25
$604.2M
$174.6M
Q3 25
$644.1M
$131.3M
Q2 25
$503.8M
$81.2M
Q1 25
$479.5M
$101.6M
Q4 24
$470.6M
$118.5M
Q3 24
$381.0M
$105.3M
Q2 24
$363.7M
$126.2M
Total Debt
ALHC
ALHC
FTRE
FTRE
Q1 26
Q4 25
$323.2M
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
Q3 24
$212.0M
Q2 24
$211.7M
Stockholders' Equity
ALHC
ALHC
FTRE
FTRE
Q1 26
$206.9M
Q4 25
$179.3M
$563.5M
Q3 25
$161.9M
$580.8M
Q2 25
$141.0M
$589.2M
Q1 25
$108.1M
$858.8M
Q4 24
$99.9M
$1.4B
Q3 24
$114.5M
$1.5B
Q2 24
$123.7M
$1.5B
Total Assets
ALHC
ALHC
FTRE
FTRE
Q1 26
$1.3B
Q4 25
$1.1B
$2.7B
Q3 25
$1.1B
$2.7B
Q2 25
$1.0B
$2.8B
Q1 25
$895.6M
$3.1B
Q4 24
$782.1M
$3.6B
Q3 24
$692.3M
$3.7B
Q2 24
$716.3M
$3.6B
Debt / Equity
ALHC
ALHC
FTRE
FTRE
Q1 26
Q4 25
1.80×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
Q3 24
1.85×
Q2 24
1.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
FTRE
FTRE
Operating Cash FlowLast quarter
$128.7M
$129.1M
Free Cash FlowOCF − Capex
$121.6M
FCF MarginFCF / Revenue
18.4%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
11.27×
TTM Free Cash FlowTrailing 4 quarters
$88.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
FTRE
FTRE
Q1 26
$128.7M
Q4 25
$-50.4M
$129.1M
Q3 25
$144.6M
$86.8M
Q2 25
$29.1M
$21.8M
Q1 25
$16.6M
$-124.2M
Q4 24
$-8.7M
$17.1M
Q3 24
$26.2M
$-2.4M
Q2 24
$23.5M
$273.7M
Free Cash Flow
ALHC
ALHC
FTRE
FTRE
Q1 26
Q4 25
$-55.4M
$121.6M
Q3 25
$139.1M
$79.5M
Q2 25
$21.1M
$14.3M
Q1 25
$8.4M
$-127.1M
Q4 24
$-18.0M
$13.9M
Q3 24
$16.9M
$-10.6M
Q2 24
$11.8M
$262.5M
FCF Margin
ALHC
ALHC
FTRE
FTRE
Q1 26
Q4 25
-5.5%
18.4%
Q3 25
14.0%
11.3%
Q2 25
2.1%
2.0%
Q1 25
0.9%
-19.5%
Q4 24
-2.6%
2.0%
Q3 24
2.4%
-1.6%
Q2 24
1.7%
39.6%
Capex Intensity
ALHC
ALHC
FTRE
FTRE
Q1 26
Q4 25
0.5%
1.1%
Q3 25
0.6%
1.0%
Q2 25
0.8%
1.1%
Q1 25
0.9%
0.4%
Q4 24
1.3%
0.5%
Q3 24
1.3%
1.2%
Q2 24
1.7%
1.7%
Cash Conversion
ALHC
ALHC
FTRE
FTRE
Q1 26
11.27×
Q4 25
Q3 25
38.77×
Q2 25
1.86×
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons